Clene Inc. Form 8-K Summary
Business Context and Reporting Period
Clene Inc. filed a Form 8-K reporting a Nasdaq continued-listing deficiency. The report date was January 30, 2024, and the filing was signed on January 31, 2024. No operating or financial results were reported.
Key Financial and Listing Metrics
- Minimum bid price requirement: Nasdaq requires a closing bid price of at least $1.00 per share.
- Deficiency: Clene’s common stock had closed below $1.00 for 30 consecutive business days.
- Additional compliance period: Nasdaq granted an additional 180 calendar days, through July 29, 2024, to regain compliance.
- Trading status: The common stock remained listed on the Nasdaq Capital Market under the symbol CLNN, with no immediate effect on its listing.
- Financial information: The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes, Outlook, and Risks
The company did not regain compliance during its initial 180-day compliance period, which expired January 29, 2024. Nasdaq determined that Clene met the market value of publicly held shares requirement and all other applicable initial-listing requirements, except the minimum bid price requirement.
Clene notified Nasdaq on January 16, 2024, of its intention to cure the deficiency during the additional compliance period. The company stated that it may effect a reverse stock split if necessary.
If the stock’s bid price closes at $1.00 or more for at least 10 consecutive business days during the additional period, Nasdaq will provide written confirmation of compliance. If Clene does not regain compliance by July 29, 2024, Nasdaq may issue a delisting notice. The company could then appeal the determination to a Nasdaq hearings panel.
Clene stated that it will monitor the bid price and consider available options, but cautioned that there is no assurance it will regain compliance or maintain compliance with other Nasdaq requirements.
Investor Verification Items
- Verify whether Clene regained compliance with Nasdaq’s $1.00 minimum bid price requirement by July 29, 2024.
- Determine whether the company implemented, proposed, or obtained shareholder approval for a reverse stock split.
- Check for subsequent Nasdaq delisting notices, hearings-panel proceedings, or changes in the trading venue.
- Review subsequent filings for liquidity, financing needs, dilution risk, and the company’s ability to maintain other continued-listing requirements.